Back
Royal Gold Vs. Cytokinetics Industry Stock Comparison
Sell
50
RGLD
Royal Gold
Last Price:
123.17
Seasonality Move:
8.3%
Buy
52
CYTK
Cytokinetics
Last Price:
52.86
Seasonality Move:
5.69%
Sell
50
Royal Gold (RGLD)
is a Sell
Is Royal Gold a Buy, Sell or Hold?
- The current Royal Gold [RGLD] share price is $124.57. The Score for RGLD is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- RGLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Cytokinetics (CYTK)
is a Buy
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $53.85. The Score for CYTK is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RGLD Stock Price Chart
What is Royal Gold's stock price today?
-
The Royal Gold share price today is $124.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGLD is experiencing selling pressure, which indicates risk of future bearish movement.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $53.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight buying pressure.
RGLD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.82 | Sell |
Relative Strength Index (14 RSI): | 48.81 | Sell |
Chaikin Money Flow: | -172925 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (122.83 - 130.85) | Sell |
Bollinger Bands (100): | (110.76 - 127.04) | Buy |
CYTK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.4 | Sell |
Relative Strength Index (14 RSI): | 47.99 | Sell |
Chaikin Money Flow: | 69998 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.06 - 56.58) | Buy |
Bollinger Bands (100): | (56.38 - 74.98) | Sell |
RGLD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 122.76 | Buy |
20-day SMA: | 125.5 | Sell |
50-day SMA: | 125.15 | Sell |
200-day SMA: | 116.26 | Buy |
8-day EMA: | 123.83 | Buy |
20-day EMA: | 124.81 | Sell |
50-day EMA: | 124.09 | Buy |
200-day EMA: | 119 | Buy |
CYTK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.08 | Buy |
20-day SMA: | 51.6 | Buy |
50-day SMA: | 58.73 | Sell |
200-day SMA: | 55.73 | Sell |
8-day EMA: | 53.02 | Buy |
20-day EMA: | 53.6 | Buy |
50-day EMA: | 57.71 | Sell |
200-day EMA: | 56.9 | Sell |
Royal Gold Earnings Growth & RGLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.10 per share, an increase this year of $1.05 per share, and an increase next year of $1.21 per share.
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.02 per share, an increase this year of $0.56 per share, and an increase next year of $0.15 per share.
Royal Gold Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cytokinetics Technical Analysis
Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |